CompletedPhase 1/2

Impact of Vitamin D Supplementation on Fetomaternal Outcomes in LTBI Pregnant Females

Pakistan99 participantsStarted 2023-09-01

Plain-language summary

The goal of this randomized controlled trial is to see the effect of vitamin D supplementation on fetomaternal outcomes in pregnant females with Latent Tuberculosis infection The main question\[s\] it aims to answer are: If Vitamin D supplementation has any impact on maternal outcomes. If Vitamin D supplementation has any impact on fetal outcomes.

Who can participate

Age range18 Years – 35 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: \- Pregnant females aged 18-35 years, already enrolled for delivery in the specified setting coming regularly for prenatal checkups with positive tuberculin skin test Exclusion Criteria: * History of active T.B * Use of any dietary supplement containing more than 400 IU/day (10 mcg/day) of vitamin D within the month before enrolment; * Presence of any confounders;

What they're measuring

Pre-Eclampsia (Maternal Outcome)

Timeframe: Three months

Gestational Diabetes Mellitus (Maternal Outcome)

Timeframe: Three months

C/Section delivery (Maternal Outcomes)

Timeframe: Three months

Low Birth Weight (Foetal Outcome)

Timeframe: One month

Pre-Term delivery (Foetal Outcome)

Timeframe: One month

Apgar Score (Foetal Outcome)

Timeframe: One month

Trial details

NCT IDNCT06354621

SponsorUniversity of the Punjab

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-02-28

View on ClinicalTrials.gov More Maternal and Child Health trials